Interestingly, IL4I1 is secreted and found in serum [56] where it promotes a tumor-prone microenvironment, increasing the concentration of metabolites in the patient’s biological fluids, including malignant gliomas patients’ cerebrospinal fluid [57–59]. Here, IL4I1 is linked to malignant glioma.